Mr. Tarek Al-Hammouri is a Robotic Urology Surgeon, originally from Jordan, currently working at the University College London Hospitals. He is an Honorary Researcher at the Department of Targeted Intervention at University College London, UK. He is also an Honorary Researcher at Queen Mary University of London, Barts Cancer Institute, London, UK.
He moved to the UK in 2018 after completing his training years at The Specialty Hospital in Amman, Jordan. He worked as an associate specialist at Royal Berkshire Hospitals in Reading, UK. He went on to UCLH in 2019 to complete successive fellowship training in Focal therapy and Robotic Surgery.
Mr. Al-Hammouri is specialised in Prostate diseases, uro-oncology, focal and robotic radical surgery. He has been involved in several scientific papers published in peer-reviewed impact factor scientific journals, most notably and recently, was the iROC Trial published in JAMA in 2022.
His main professional and scientific interests focus on prostate cancer management, minimally invasive urologic surgery, training and education in surgery, patient-reported outcomes and healthcare management.
Selected publications from PubMed
Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomy.
Beatrici E, de Angelis M, Almeida-Magana R, Al-Hammouri T, Fiori C, Piramide F, Plopeanu A, Frego N, Schiavina R, Barretta A, Silvanto A, Eapen RS, Barod R, Oxley J, Mazzone E, Winkler M, Mayor N, Van Der Steen K, Farinha R, Ferretti S, Bianchi G, Rodriguez Peñaranda N, Autorino R, Kaouk J, Olivares R, Weight CJ, Soputro NA, Reggiani Bonetti L, Eccher A, Sighinolfi MC, Cavarra V, Pepillo F, Gallagher AG, Murphy DG, Wiklund P, Hamdy FC, Puliatti S, Mottrie A, Shaw G, De Groote R
BJU Int. 2026 Jun;138 Suppl 1(Suppl 1):S11-S21 doi: 10.1111/bju.70353.
The LaserSAFE technique for margin assessment during radical prostatectomy: a feasibility study.
Almeida-Magana R, Mendes LST, Dinneen E, Al-Hammouri T, Haider A, Silvanto A, Freeman A, Roberts N, Dickinson L, So CW, Tandogdu Z, Lamb BW, Mayor N, Winkler M, Ahmed H, Shaw G
BJU Int. 2026 Jun;138 Suppl 1(Suppl 1):S22-S30 doi: 10.1111/bju.70092.
Urinary continence after robot-assisted radical prostatectomy with complete urethral preservation.
Yousaf A, Almeida-Magana R, Dineen E, Al-Hammouri T, Tandogdu Z, Shaw G
BJUI Compass. 2026 May;7(5):e70230 doi: 10.1002/bco2.70230.
The 'Comparison of diagnostic accuracy of Luminal Index and standard of care MRI for Accelerated deTEction of prostate cancer' (CLIMATE) trial protocol.
Al-Hammouri T, Brembilla G, Brizmohun M, Tuazon J, Clemente J, Mathew M, Potyka I, Brew-Graves C, Markus J, Giganti F, Parry T, Haider A, Mallett S, Dudderidge T, Barrett T, Attard G, Moore C, Punwani S, CLIMATE Trial Management Group
BJU Int. 2026 Apr;137(4):611-618 doi: 10.1111/bju.70108.
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trial.
Dinneen E, Almeida-Magana R, Al-Hammouri T, Pan S, Leurent B, Haider A, Freeman A, Roberts N, Brew-Graves C, Grierson J, Clow R, Williams N, Aning J, Walton T, Persad R, Oakley N, Ahmad I, Dutto L, Briggs T, Allen C, Tandogdu Z, Adshead J, Oxley J, Kelly J, Shaw G, NeuroSAFE PROOF Investigators
Lancet Oncol. 2025 Apr;26(4):447-458 doi: 10.1016/S1470-2045(25)00091-9.
Help your network discover Dr. Tarek Al-Hammouri's clinical expertise.
